Annotated Medicine and Device Lists


Tenofovir disoproxil fumarate

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.4.4.1.1 Nucleoside/Nucleotide reverse transcriptase inhibitors No observations
WHO Model List of Essential Medicines (2021) 6.4.2.1. Nucleoside/Nucleotide reverse transcriptase inhibitors Others observations:
(tenofovir disoproxil fumarate – equivalent to 245 mg tenofovir disoproxil).
PAHO Strategic Fund Medicine List 2.5. Antiretrovirals No observations
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Anti-Retroviral Treatment Programme No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
FCO X 30 TAB
Costa Rica. Caja Costarricense de Seguro Social. 2019 04. Antifungicos y Antivirales No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations
El Salvador - 2019 ANTIVIRALES DE USO SISTÉMICO No observations
Haiti. National List of Essential Medicines 06.04.02.01 Nucleoside reverse transcriptase inhibitors No observations
Haiti. National List of Essential Medicines 06.04.04.01.01 Nucleoside/nucleotide reverse transcriptase inhibitors No observations

This medicine is present in:

List Section Observation
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 05 ANTIVIRALES DE USO SISTÉMICO No observations
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations

Information Resources: Tenofovir disoproxil fumarate

Loading ...
Loading ...
Loading ...
No information available